Records containing: Stem Cell Transplant Complications
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-27An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects With Epstein Barr Virus Associated Diseases (EBVision)
-
CLINICAL_TRIALS study record update · 2026-04-13Multidisciplinary Intervention for Adults With Chronic Graft Versus Host Disease
-
CLINICAL_TRIALS study record update · 2026-04-03Prospective Randomized Controlled Trial of Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease)
-
CLINICAL_TRIALS study record update · 2026-03-19Multi-Site Randomized Controlled Trial of a Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
-
CLINICAL_TRIALS study record update · 2026-02-24Intestinal Microbiota Alteration by Antibiotics Used During Stem Cell Transplant Admission
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-20An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects With Epstein Barr Virus Associated Diseases (EBVision)
-
CLINICAL_TRIALS study record update · 2026-02-20Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy
-
CLINICAL_TRIALS study record update · 2026-02-05Loratadine for the Prevention of Bone Pain Caused by Granulocyte Colony Stimulating Factor (G-CSF) During Stem Cell Mobilization
-
CLINICAL_TRIALS study record update · 2026-01-22Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation: The PROTECT Trial
-
CLINICAL_TRIALS study record update · 2026-01-22Addition of Venetoclax to Combined Reduced Intensity Hematopoietic Stem Cell and Kidney Transplantation for Patients With Chronic Kidney Disease and Hematologic Malignancy
-
CLINICAL_TRIALS study record update · 2026-01-20Multidisciplinary Intervention to Promote Medical Adherence and Coping in Patients With Moderate to Severe Chronic Graft-Versus-Host Disease (GVHD
-
CLINICAL_TRIALS study record update · 2026-01-14Novel First-line Therapies for Grade II Acute GVHD: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-01-08Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
-
CLINICAL_TRIALS study record update · 2026-01-08Measuring Cognition, Physical Function, and Quality of Life After Hematopoietic Cell Transplantation in Adults >/= 60 Years: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2025-12-08The Effect of Medical Treatment on Muscle Dysfunction and the Prognostic Role of Muscle Dysfunction at Critical Decision Points in Patients With Hematological Diseases Referred to Myeloablative Hematopoietic Stem Cell Transplant (HSCT), to Myeloablative HSCT With a "Reduced Toxicity Conditioning" Regime With Fludarabine and Treosulfane (FluTreo), or to Non-myeloablative HSCT. - A Prospective Observational Study.
-
CLINICAL_TRIALS study record update · 2025-12-03A Multicenter Clinical Study of a TPO Receptor Agonist (Eltrombopag) in the Acceleration of Engraftment Post Hematopoietic Stem Cell Transplantation of Bone Marrow Failure Diseases
-
CLINICAL_TRIALS study record update · 2025-11-14Delirium in Children Undergoing Stem Cell Transplantation: Epidemiology and Outcomes
-
CLINICAL_TRIALS study record update · 2025-10-20Ciprofloxacin Versus Levofloxacin and Rate of Breakthrough Infections in Hematopoietic Stem Cell Transplant Patients
-
CLINICAL_TRIALS study record update · 2025-10-20A Pilot/Phase 1 Study of Immunosuppression-free Regulatory T-cell Graft-engineered Haploidentical Hematopoietic Cell Transplantation in Relapsed/Refractory and Ultra-High-risk AML/MDS
-
CLINICAL_TRIALS study record update · 2025-09-16Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation
-
CLINICAL_TRIALS study record update · 2025-08-05Pilot Study to Develop a Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing Blood and Marrow Transplantation
-
CLINICAL_TRIALS study record update · 2025-07-18Treatment of Chemo-refractory Viral Infections After Allogeneic Stem Cell Transplantation With Multispecific T Cells Against CMV, EBV and AdV: A Phase III, Prospective, Multicentre Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-07-15Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
-
CLINICAL_TRIALS study record update · 2025-07-04A Randomized, Multicenter, Open-label Phase II Trial to Compare Prophylaxis of Graft Versus Host Disease With Tacrolimus and Mycophenolate Mofetil Versus Ruxolitinib After Post-transplant Cyclophosphamide
-
CLINICAL_TRIALS study record update · 2025-06-08Nutritional Support With TGF-β2 Food for Special Medical Purposes (TGF-β2 FSMP) in Adult Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for the Prevention of Malnutrition: a Prospective, Randomized, Multicenter Study - (TGF-NUTRIALLO Study)